Skip to main content
Erschienen in: Obesity Surgery 9/2020

13.04.2020 | Original Contributions

Bariatric Surgery in Patients with Cirrhosis: Careful Patient and Surgery-Type Selection Is Key to Improving Outcomes

verfasst von: Khalid Mumtaz, Hannah Lipshultz, Sajid Jalil, Kyle Porter, Na Li, Sean G. Kelly, Lanla F. Conteh, Anthony Michaels, James Hanje, Sylvester Black, Hisham Hussan

Erschienen in: Obesity Surgery | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Previous reports suggest an increased mortality in cirrhotic patients undergoing bariatric surgery (BS). With advancements in management of BS, we aim to study the trends, outcomes, and their predictors in patients with cirrhosis undergoing BS.

Materials and Methods

A retrospective study was performed using the National Database from 2008 to 2013. Outcomes of BS in patients with cirrhosis were studied. In-hospital mortality, length of stay, and cost of care were compared between patients with no cirrhosis (NC), compensated cirrhosis (CC), and decompensated cirrhosis (DC). Multivariable logistic regression analysis was performed to study the predictors of mortality.

Results

Of the 558,017 admissions of patients who underwent BS during the study period, 3086 (0.55%) had CC and 103 (0.02%) had DC. An upward trend of vertical sleeve gastrectomy (VSG) utilization was seen during the study period. On multivariate analysis, mortality in CC was comparable with those in NC (aOR 1.88; CI 0.65–5.46); however, it was higher in DC (aOR 83.8; CI 19.3–363.8). Other predictors of mortality were older age (aOR 1.06; CI 1.04–1.08), male (aOR 2.59; CI 1.76–3.81), Medicare insurance (aOR 1.93; CI 1.24–3.01), lower income (aORs 0.44 to 0.55 for 2nd to 4th income quartile vs. 1st quartile), > 3 Elixhauser Comorbidity Index (aOR 5.30; CI 3.45–8.15), undergoing Roux-en-Y gastric bypass as opposed to VSG (aOR 3.90; CI 1.79–8.48), and centers performing < 50 BS per year (aOR 5.25; CI 3.38–8.15). Length of stay and hospital cost were also significantly higher in patients with cirrhosis as compared with those with NC.

Conclusion

Patients with compensated cirrhosis can be considered for bariatric surgery. However, careful selection of patients, procedure type, and volume of surgical center is integral in improving outcomes and healthcare utilization in patients with cirrhosis undergoing BS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Gloy VL. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. Br Med J. 2013;347:f5934.CrossRef Gloy VL. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. Br Med J. 2013;347:f5934.CrossRef
3.
Zurück zum Zitat Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surgery. 2015;150(10):931–40.CrossRef Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surgery. 2015;150(10):931–40.CrossRef
4.
Zurück zum Zitat Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.CrossRef Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.CrossRef
5.
Zurück zum Zitat Lassailly G, Caiazo R, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149:379–88.CrossRef Lassailly G, Caiazo R, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149:379–88.CrossRef
6.
Zurück zum Zitat Parker BM, Wu J, et al. Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery. BMC Obesity. 2017;4:32.CrossRef Parker BM, Wu J, et al. Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery. BMC Obesity. 2017;4:32.CrossRef
7.
Zurück zum Zitat Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:897–901.CrossRef Mosko JD, Nguyen GC. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:897–901.CrossRef
8.
Zurück zum Zitat Khan S, Rock K, Baskara A, et al. Jorge Ortiz, trends in bariatric surgery from 2008 to 2012. Am J Surg. 2016;211(6):1041–6.CrossRef Khan S, Rock K, Baskara A, et al. Jorge Ortiz, trends in bariatric surgery from 2008 to 2012. Am J Surg. 2016;211(6):1041–6.CrossRef
10.
Zurück zum Zitat de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–76.CrossRef de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–76.CrossRef
11.
Zurück zum Zitat Mumtaz K, Issak A, Porter K, et al. Validation of risk score in predicting early readmissions in decompensated cirrhotic patients: a model based on the administrative database. Hepatology. 2019;70(2):630–9.CrossRef Mumtaz K, Issak A, Porter K, et al. Validation of risk score in predicting early readmissions in decompensated cirrhotic patients: a model based on the administrative database. Hepatology. 2019;70(2):630–9.CrossRef
12.
Zurück zum Zitat Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.CrossRef Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.CrossRef
13.
Zurück zum Zitat Goh GB, Schauer PR, McCullough AJ. Considerations for bariatric surgery in patients with cirrhosis. World J Gastroenterol. 2018;24(28):3112–9.CrossRef Goh GB, Schauer PR, McCullough AJ. Considerations for bariatric surgery in patients with cirrhosis. World J Gastroenterol. 2018;24(28):3112–9.CrossRef
14.
Zurück zum Zitat Cobb WS, Heniford BT, Burns JM, et al. Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc. 2005;19:418–23.CrossRef Cobb WS, Heniford BT, Burns JM, et al. Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc. 2005;19:418–23.CrossRef
15.
Zurück zum Zitat Shimizu H, Phuong V, Maia M, et al. Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis. 2013;9:1–6.CrossRef Shimizu H, Phuong V, Maia M, et al. Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis. 2013;9:1–6.CrossRef
16.
Zurück zum Zitat Wolter S, Duprée A, Coelius C, et al. Influence of liver disease on perioperative outcome after bariatric surgery in a Northern German cohort. Obes Surg. 2017;27:90–5.CrossRef Wolter S, Duprée A, Coelius C, et al. Influence of liver disease on perioperative outcome after bariatric surgery in a Northern German cohort. Obes Surg. 2017;27:90–5.CrossRef
17.
Zurück zum Zitat Rebibo L, Gerin O, Verhaeghe P, et al. Laparoscopic sleeve gastrectomy in patients with NASHrelated cirrhosis: a case-matched study. Surg Obes Relat Dis. 2014;10:405–10.CrossRef Rebibo L, Gerin O, Verhaeghe P, et al. Laparoscopic sleeve gastrectomy in patients with NASHrelated cirrhosis: a case-matched study. Surg Obes Relat Dis. 2014;10:405–10.CrossRef
18.
Zurück zum Zitat Li JF, Lai DD, Ni B, et al. Comparison of laparoscopic Rouxen-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg. 2013;56:E158–64.CrossRef Li JF, Lai DD, Ni B, et al. Comparison of laparoscopic Rouxen-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Can J Surg. 2013;56:E158–64.CrossRef
19.
Zurück zum Zitat Sherman S, Shaked A, Cryer HM, et al. Endoscopic management of biliary fistulas complicating liver transplantation and other hepatobiliary operations. Ann Surg. 1993;218:167–75.CrossRef Sherman S, Shaked A, Cryer HM, et al. Endoscopic management of biliary fistulas complicating liver transplantation and other hepatobiliary operations. Ann Surg. 1993;218:167–75.CrossRef
20.
Zurück zum Zitat GehrerS KB, PetersT C-CC, Peterli R. Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy than after laparoscopic Roux-Y-gastric bypass—a prospective study. Obes Surg. 2010;20:447–53.CrossRef GehrerS KB, PetersT C-CC, Peterli R. Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy than after laparoscopic Roux-Y-gastric bypass—a prospective study. Obes Surg. 2010;20:447–53.CrossRef
21.
Zurück zum Zitat Saab S, Lalezari D, Pruthi P, et al. The impact of obesity on patient survival in liver transplant recipients: a meta-analysis. Liver Int. 2015;35:164–70.CrossRef Saab S, Lalezari D, Pruthi P, et al. The impact of obesity on patient survival in liver transplant recipients: a meta-analysis. Liver Int. 2015;35:164–70.CrossRef
22.
Zurück zum Zitat Perez-Protto SE, Quintini C, Reynolds LF, et al. Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl. 2013;19:907–15.CrossRef Perez-Protto SE, Quintini C, Reynolds LF, et al. Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl. 2013;19:907–15.CrossRef
23.
Zurück zum Zitat Terjimanian MN, Harbaugh CM, Hussain A, et al. Abdominal adiposity, body composition and survival after liver transplantation. Clin Transpl. 2016;30:289–94.CrossRef Terjimanian MN, Harbaugh CM, Hussain A, et al. Abdominal adiposity, body composition and survival after liver transplantation. Clin Transpl. 2016;30:289–94.CrossRef
24.
Zurück zum Zitat Hamaguchi Y, Kaido T, Okumura S, et al. Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation. 2017;101:565–74.CrossRef Hamaguchi Y, Kaido T, Okumura S, et al. Impact of skeletal muscle mass index, intramuscular adipose tissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation. 2017;101:565–74.CrossRef
Metadaten
Titel
Bariatric Surgery in Patients with Cirrhosis: Careful Patient and Surgery-Type Selection Is Key to Improving Outcomes
verfasst von
Khalid Mumtaz
Hannah Lipshultz
Sajid Jalil
Kyle Porter
Na Li
Sean G. Kelly
Lanla F. Conteh
Anthony Michaels
James Hanje
Sylvester Black
Hisham Hussan
Publikationsdatum
13.04.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 9/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04583-4

Weitere Artikel der Ausgabe 9/2020

Obesity Surgery 9/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.